(Q34562817)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

main subject

mucopolysaccharidosis I

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Juan Llerena Jr.

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Marcia G. Ribeiro

36

0 references

Laura Bannach Jardim

30

Laura Jardim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1

Roberto Giugliani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

Marcelo Soares Kerstenetzky

2 February 2020

35

Marcelo Kerstenetzky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

40

Rachel Honjo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

Dafne Dain Gandelman Horovitz

2 February 2020

12

Dafne Horovitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Erlane Marques Ribeiro

18

Erlane Ribeiro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

Andressa Federhen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

Maria Verônica Muñoz Rojas

2 February 2020

3

Maria Verônica Muñoz Rojas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

5

Osvaldo Artigalás

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

7

Ana Cecília Azevedo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

10

Charles Marques Lourenço

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

14

Denise Norato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

15

Diane Marinho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Durval Batista Palhares

16

Durval Palhares

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

Emerson de Santana Santos

2 February 2020

17

Emerson Santana Santos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

20

Fábio Guarany

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Gisele Rosone de Lucca

21

Gisele Rosone de Lucca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Taiane Vieira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Louise Lapagesse Pinto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Angelina Acosta

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Carmen Bonfim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Denize Bonfim

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Eugênia Valadares

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Helena Pimentel

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Isabel Neves de Souza

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jordão Correa

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

José Carlos Fraga

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

José Eduardo Goes

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

José Maria Cabral

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

José Simionato

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Liane Giuliani

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Luiz Carlos Santana da Silva

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Mara L Santos

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Maria Angela Moreira

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Márcia Ribeiro

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Nicole Ruas

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Patricia Barrios

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Paulo Aranda

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Raquel Boy

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Ronaldo Costa

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Carolina Souza

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Flavio F Alcantara

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Silvio Gilberto A Avilla

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Simone Fagondes

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Ana Maria Martins

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

Genetics and Molecular Biology

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

589-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

Mucopolysaccharidosis I: management and treatment guidelines

2 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

The clinical outcome of Hurler syndrome after stem cell transplantation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Successful management of difficult infusion-associated reactions in a young patient with mucopolysaccharidosis type VI receiving recombinant human arylsulfatase B (galsulfase [Naglazyme])

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Management guidelines for mucopolysaccharidosis VI.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Mucopolysaccharidosis type II: an update on mutation spectrum

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

A clinical study of 77 patients with mucopolysaccharidosis type II

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Trends in haematopoietic cell transplantation for inborn errors of metabolism

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Anesthesia for an adult with mucopolysaccharidosis I.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Mucopolysaccharidosis type II in females: case report and review of literature.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Prediction of neuropathology in mucopolysaccharidosis I patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Enzyme replacement therapy for the mucopolysaccharide storage disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

The frequency of lysosomal storage diseases in The Netherlands.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Prevalence of lysosomal storage disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Receptor mediated binding of two glycosylation forms of N-acetylgalactosamine-4-sulphatase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Incidence of the mucopolysaccharidoses in Northern Ireland

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Bone marrow transplantation in Hunter syndrome.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I.

7 July 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Glycosaminoglycans in neonatal urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Enzyme-replacement therapy in mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Enzyme replacement therapy in feline mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Mutational analysis of 105 mucopolysaccharidosis type VI patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Idursulfase in Hunter syndrome treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036139

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

27 October 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1415-47572010005000093

Home treatment with enzyme replacement therapy for mucopolysaccharidosis type I is feasible and safe

21 January 2018

1 reference

12 December 2020

An update on the frequency of mucopolysaccharide syndromes in British Columbia

1 reference

12 December 2020

Left ventricular aneurysm in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): clinical and pathological correlation

1 reference

12 December 2020

Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation

1 reference

12 December 2020

Identification of a Novel Mutation in the ARSB Gene That Is Frequent Among Brazilian MPSVI Patients

1 reference

12 December 2020

Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy

1 reference

12 December 2020

Hunter syndrome (MPS II-B): a report of bilateral vitreous floaters and maculopathy

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study

1 reference

12 December 2020

Incidence of the mucopolysaccharidoses in Western Australia

1 reference

12 December 2020

Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage Diseases

1 reference

12 December 2020

Clinical and laboratorial study of 19 cases of mucopolysaccharidoses

1 reference

12 December 2020

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

1 reference

12 December 2020

Unique frequency of known mutations in Brazilian MPS I patients

1 reference

12 December 2020

Valvular heart disease in four patients with Maroteaux-Lamy syndrome

1 reference

12 December 2020

Images in cardiovascular medicine. Left ventricular aneurysm associated with mucopolysaccharidosis type VI syndrome (Maroteaux-Lamy syndrome)

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

12 December 2020

Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats

1 reference

12 December 2020

Cumulative incidence rates of the mucopolysaccharidoses in Germany

1 reference

12 December 2020

Permanent transfemoral pacemaker implantation in a child with Maroteaux Lamy syndrome

1 reference

12 December 2020

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I

1 reference

12 December 2020

Bone marrow transplantation in patients with storage diseases: a developing country experience

1 reference

12 December 2020

Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

1 reference

12 December 2020

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression

1 reference

12 December 2020

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

Significance of extensive Mongolian spots in Hunter's syndrome

1 reference

12 December 2020

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I

1 reference

12 December 2020

[Consensus on mucopolysaccharidosis type I diagnosis and treatment]

1 reference

12 December 2020

Successful treatment of severe heart failure in an infant with Hurler syndrome

1 reference

12 December 2020

Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism

1 reference

12 December 2020

Advantages of using same species enzyme for replacement therapy in a feline model of mucopolysaccharidosis type VI

1 reference

12 December 2020

Postnatal and prenatal diagnosis of Maroteaux-Lamy syndrome

1 reference

12 December 2020

Idursulfase for the treatment of mucopolysaccharidosis II

1 reference

12 December 2020

Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI

1 reference

12 December 2020

10.1590/S1415-47572010005000093

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21637564%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

PubMed publication ID

21637564

1 reference